Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap
Research payments
$2,286,109
Through program year 2023, $2,286,109 in research payments was reported against Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap, across 2,911 payments, paid by Alcon Research LLC.
- Paid by
- Alcon Research LLC
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $8,000 | 8 |
| 2022 | Research | $146,972 | 250 |
| 2021 | Research | $1,538,809 | 2,105 |
| 2020 | Research | $592,327 | 548 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Andrew Moyes Kansas City, MO Named on 621 payments
- Michael Gordon San Diego, CA Named on 548 payments
- Thomas Clinch Chevy Chase, MD Named on 357 payments
- Jeffrey Whitman Dallas, TX Named on 352 payments
- Vance Thompson Sioux Falls, SD Named on 337 payments
- William Dupps Cleveland, OH Named on 192 payments
- Stephen Wexler Richmond Heights, MO Named on 191 payments
- Kerry Solomon Mt Pleasant, SC Named on 157 payments
- Francis Price Indianapolis, IN Named on 144 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.